Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia)
Clinical trial NCT01604811 · COMPLETED
Trial details
- NCT number
- NCT01604811
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-10-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.